References
- Alfaro TM, Duarte C, Monteiro R, Simao A, Calretas S, Nascimento Costa JM. Churg-Strauss syndrome: case series. Rev Port Pneumol. 2012;18(2):86–92.
- Murakami S, Misumi M, Sakata H, Hirayama R, Kubojima Y, Nomura K, Ban S. Churg-Strauss syndrome manifesting as perforation of the small intestine: report of a case. Surg Today. 2004;34(9): 788–92.
- Zanaboni D, Maccabruni A, Bonacci E, Caprioli M, Caporali R, Mariani B. Churg-Strauss syndrome: a diagnosis not to be forgotten. New Microbiol. 2008;31(2):285–90.
- Alvarez C, Asensi V, Rodriguez-Guardado A, Casado L, Ablanedo P, Alvarez-Navascues C. Unusual complications in the Churg-Strauss syndrome. Ann Rheum Dis. 2002;61(1):94–5.
- Nagasawa T, Yoshida M. Clinical features of allergic granulomatous angiitis in Japan and a proposal for guidelines for clinical diagnosis of this disease [Japanese]. Nihon Naikagakkaizasshi. 1989;78:352–6.
- Venditti D, Valerio B, Ielpo B, Buonomo O, Petrella G. Bowel perforations in a patient affected by Churg-Strauss syndrome under high-dose steroid treatment: will alternative drugs reduce risk of surgery? Rheumatol Int. 2011;31:1239–41.
- Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013;65:270–81.
- Nakamura Y, Sakurai Y, Matsubara T, Nagai T, Fukaya S, Imazu H, et al. Multiple perforated ulcers of the small intestine associated with allergic granulomatous angiitis: report of a case. Surg Today 2002;32(6):541–6.
- Zerler B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells. 1991;3(12):471–9.
- Kaito K, Otsubo H, Ogasawara Y, Kimura H, Kurihara E, Koike M, et al. Serum soluble interleukin-2 receptor in eosinophilia. Acta Haematol. 2003;109(1):23–8.
- Sinico RA, Bottero P. Churg-Strauss angiitis. Best Pract Res Clin Rheumatol. 2009;23(3):355–66.
- Pepper RJ, Fabre MA, Pavesio C, Gaskin G, Jones RB, Jayne D, et al. Rituximab is effective in the treatment of refractory Churg- Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology (Oxford). 2008;47(7): 1104–5.